Guerbet SA
Guerbet SA (GUERF) Stock Competitors & Peer Comparison
See (GUERF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GUERF | $22.25 | +0.00% | 281M | 8.19 | $2.72 | N/A |
| SRTOY | $19.61 | -4.41% | 190.8B | 75.44 | $0.26 | +0.39% |
| ESLOY | $148.37 | +0.41% | 136.8B | 50.47 | $2.94 | +1.52% |
| ESLOF | $298.82 | +0.08% | 135.6B | 49.16 | $5.98 | +1.51% |
| MECNY | $88.63 | +0.00% | 107.8B | N/A | N/A | N/A |
| SOAGY | $41.81 | -2.02% | 65.2B | 122.97 | $0.34 | +0.20% |
| RSMDF | $30.00 | +21.11% | 49.6B | 31.58 | $0.95 | +0.73% |
| HOCPF | $126.44 | +6.24% | 43.3B | 32.34 | $3.91 | +0.86% |
| HOCPY | $123.78 | +6.52% | 42.4B | 31.82 | $3.89 | +0.42% |
| TRUMY | $17.33 | +1.94% | 25.5B | 32.66 | $0.53 | +0.61% |
Stock Comparison
GUERF vs SRTOY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SRTOY has a market cap of 190.8B. Regarding current trading prices, GUERF is priced at $22.25, while SRTOY trades at $19.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SRTOY's P/E ratio is 75.44. In terms of profitability, GUERF's ROE is N/A, compared to SRTOY's ROE of +0.05%. Regarding short-term risk, GUERF and SRTOY have similar daily volatility (0.00).Check SRTOY's competition here
GUERF vs ESLOY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, ESLOY has a market cap of 136.8B. Regarding current trading prices, GUERF is priced at $22.25, while ESLOY trades at $148.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ESLOY's P/E ratio is 50.47. In terms of profitability, GUERF's ROE is N/A, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, GUERF is less volatile compared to ESLOY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check ESLOY's competition here
GUERF vs ESLOF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, ESLOF has a market cap of 135.6B. Regarding current trading prices, GUERF is priced at $22.25, while ESLOF trades at $298.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ESLOF's P/E ratio is 49.16. In terms of profitability, GUERF's ROE is N/A, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, GUERF is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check ESLOF's competition here
GUERF vs MECNY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, MECNY has a market cap of 107.8B. Regarding current trading prices, GUERF is priced at $22.25, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas MECNY's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to MECNY's ROE of +0.07%. Regarding short-term risk, GUERF and MECNY have similar daily volatility (0.00).Check MECNY's competition here
GUERF vs SOAGY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SOAGY has a market cap of 65.2B. Regarding current trading prices, GUERF is priced at $22.25, while SOAGY trades at $41.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SOAGY's P/E ratio is 122.97. In terms of profitability, GUERF's ROE is N/A, compared to SOAGY's ROE of +0.05%. Regarding short-term risk, GUERF and SOAGY have similar daily volatility (0.00).Check SOAGY's competition here
GUERF vs RSMDF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, RSMDF has a market cap of 49.6B. Regarding current trading prices, GUERF is priced at $22.25, while RSMDF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas RSMDF's P/E ratio is 31.58. In terms of profitability, GUERF's ROE is N/A, compared to RSMDF's ROE of +0.26%. Regarding short-term risk, GUERF is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check RSMDF's competition here
GUERF vs HOCPF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, HOCPF has a market cap of 43.3B. Regarding current trading prices, GUERF is priced at $22.25, while HOCPF trades at $126.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas HOCPF's P/E ratio is 32.34. In terms of profitability, GUERF's ROE is N/A, compared to HOCPF's ROE of +0.21%. Regarding short-term risk, GUERF and HOCPF have similar daily volatility (0.00).Check HOCPF's competition here
GUERF vs HOCPY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, HOCPY has a market cap of 42.4B. Regarding current trading prices, GUERF is priced at $22.25, while HOCPY trades at $123.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas HOCPY's P/E ratio is 31.82. In terms of profitability, GUERF's ROE is N/A, compared to HOCPY's ROE of +0.20%. Regarding short-term risk, GUERF is less volatile compared to HOCPY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check HOCPY's competition here
GUERF vs TRUMY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, TRUMY has a market cap of 25.5B. Regarding current trading prices, GUERF is priced at $22.25, while TRUMY trades at $17.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TRUMY's P/E ratio is 32.66. In terms of profitability, GUERF's ROE is N/A, compared to TRUMY's ROE of +0.09%. Regarding short-term risk, GUERF is less volatile compared to TRUMY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check TRUMY's competition here
GUERF vs TRUMF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, TRUMF has a market cap of 24B. Regarding current trading prices, GUERF is priced at $22.25, while TRUMF trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TRUMF's P/E ratio is 30.66. In terms of profitability, GUERF's ROE is N/A, compared to TRUMF's ROE of +0.09%. Regarding short-term risk, GUERF is less volatile compared to TRUMF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check TRUMF's competition here
GUERF vs CLPBF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, CLPBF has a market cap of 22.5B. Regarding current trading prices, GUERF is priced at $22.25, while CLPBF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CLPBF's P/E ratio is 32.36. In terms of profitability, GUERF's ROE is N/A, compared to CLPBF's ROE of +0.27%. Regarding short-term risk, GUERF is less volatile compared to CLPBF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check CLPBF's competition here
GUERF vs CLPBY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, CLPBY has a market cap of 20.6B. Regarding current trading prices, GUERF is priced at $22.25, while CLPBY trades at $9.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CLPBY's P/E ratio is 30.20. In terms of profitability, GUERF's ROE is N/A, compared to CLPBY's ROE of +0.27%. Regarding short-term risk, GUERF is less volatile compared to CLPBY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check CLPBY's competition here
GUERF vs SAUHY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SAUHY has a market cap of 20.2B. Regarding current trading prices, GUERF is priced at $22.25, while SAUHY trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SAUHY's P/E ratio is 36.23. In terms of profitability, GUERF's ROE is N/A, compared to SAUHY's ROE of +0.14%. Regarding short-term risk, GUERF is less volatile compared to SAUHY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check SAUHY's competition here
GUERF vs SAUHF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SAUHF has a market cap of 20B. Regarding current trading prices, GUERF is priced at $22.25, while SAUHF trades at $125.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SAUHF's P/E ratio is 33.83. In terms of profitability, GUERF's ROE is N/A, compared to SAUHF's ROE of +0.14%. Regarding short-term risk, GUERF is less volatile compared to SAUHF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check SAUHF's competition here
GUERF vs SDMHF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SDMHF has a market cap of 19.4B. Regarding current trading prices, GUERF is priced at $22.25, while SDMHF trades at $199.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SDMHF's P/E ratio is 74.25. In terms of profitability, GUERF's ROE is N/A, compared to SDMHF's ROE of +0.05%. Regarding short-term risk, GUERF and SDMHF have similar daily volatility (0.00).Check SDMHF's competition here
GUERF vs SARTF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SARTF has a market cap of 15.3B. Regarding current trading prices, GUERF is priced at $22.25, while SARTF trades at $200.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SARTF's P/E ratio is 117.08. In terms of profitability, GUERF's ROE is N/A, compared to SARTF's ROE of +0.05%. Regarding short-term risk, GUERF and SARTF have similar daily volatility (0.00).Check SARTF's competition here
GUERF vs SUVPF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SUVPF has a market cap of 13.5B. Regarding current trading prices, GUERF is priced at $22.25, while SUVPF trades at $210.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SUVPF's P/E ratio is 120.85. In terms of profitability, GUERF's ROE is N/A, compared to SUVPF's ROE of +0.05%. Regarding short-term risk, GUERF and SUVPF have similar daily volatility (0.00).Check SUVPF's competition here
GUERF vs SSSGY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SSSGY has a market cap of 13B. Regarding current trading prices, GUERF is priced at $22.25, while SSSGY trades at $42.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SSSGY's P/E ratio is 123.85. In terms of profitability, GUERF's ROE is N/A, compared to SSSGY's ROE of +0.05%. Regarding short-term risk, GUERF and SSSGY have similar daily volatility (0.00).Check SSSGY's competition here
GUERF vs FSPKF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, FSPKF has a market cap of 13B. Regarding current trading prices, GUERF is priced at $22.25, while FSPKF trades at $22.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas FSPKF's P/E ratio is 58.16. In terms of profitability, GUERF's ROE is N/A, compared to FSPKF's ROE of +0.28%. Regarding short-term risk, GUERF and FSPKF have similar daily volatility (0.00).Check FSPKF's competition here
GUERF vs OCPNF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, OCPNF has a market cap of 12.9B. Regarding current trading prices, GUERF is priced at $22.25, while OCPNF trades at $11.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas OCPNF's P/E ratio is 16.59. In terms of profitability, GUERF's ROE is N/A, compared to OCPNF's ROE of +0.16%. Regarding short-term risk, GUERF is less volatile compared to OCPNF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check OCPNF's competition here
GUERF vs SSMXY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SSMXY has a market cap of 10.5B. Regarding current trading prices, GUERF is priced at $22.25, while SSMXY trades at $16.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SSMXY's P/E ratio is 28.98. In terms of profitability, GUERF's ROE is N/A, compared to SSMXY's ROE of +0.12%. Regarding short-term risk, GUERF is less volatile compared to SSMXY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check SSMXY's competition here
GUERF vs SSMXF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SSMXF has a market cap of 9.9B. Regarding current trading prices, GUERF is priced at $22.25, while SSMXF trades at $15.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SSMXF's P/E ratio is 27.24. In terms of profitability, GUERF's ROE is N/A, compared to SSMXF's ROE of +0.12%. Regarding short-term risk, GUERF and SSMXF have similar daily volatility (0.00).Check SSMXF's competition here
GUERF vs CNVVF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, CNVVF has a market cap of 7.6B. Regarding current trading prices, GUERF is priced at $22.25, while CNVVF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CNVVF's P/E ratio is 33.64. In terms of profitability, GUERF's ROE is N/A, compared to CNVVF's ROE of +0.16%. Regarding short-term risk, GUERF and CNVVF have similar daily volatility (0.00).Check CNVVF's competition here
GUERF vs YPHDF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, YPHDF has a market cap of 7.3B. Regarding current trading prices, GUERF is priced at $22.25, while YPHDF trades at $534.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas YPHDF's P/E ratio is 67.77. In terms of profitability, GUERF's ROE is N/A, compared to YPHDF's ROE of +0.13%. Regarding short-term risk, GUERF and YPHDF have similar daily volatility (0.00).Check YPHDF's competition here
GUERF vs CNVVY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, CNVVY has a market cap of 6.3B. Regarding current trading prices, GUERF is priced at $22.25, while CNVVY trades at $12.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CNVVY's P/E ratio is 29.17. In terms of profitability, GUERF's ROE is N/A, compared to CNVVY's ROE of +0.16%. Regarding short-term risk, GUERF is less volatile compared to CNVVY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check CNVVY's competition here
GUERF vs FLMNF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, FLMNF has a market cap of 5.4B. Regarding current trading prices, GUERF is priced at $22.25, while FLMNF trades at $64.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas FLMNF's P/E ratio is 28.83. In terms of profitability, GUERF's ROE is N/A, compared to FLMNF's ROE of +0.17%. Regarding short-term risk, GUERF is less volatile compared to FLMNF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check FLMNF's competition here
GUERF vs FLMNY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, FLMNY has a market cap of 5.3B. Regarding current trading prices, GUERF is priced at $22.25, while FLMNY trades at $12.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas FLMNY's P/E ratio is 28.45. In terms of profitability, GUERF's ROE is N/A, compared to FLMNY's ROE of +0.17%. Regarding short-term risk, GUERF and FLMNY have similar daily volatility (0.00).Check FLMNY's competition here
GUERF vs ADDLF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, ADDLF has a market cap of 4.9B. Regarding current trading prices, GUERF is priced at $22.25, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, GUERF's ROE is N/A, compared to ADDLF's ROE of +0.06%. Regarding short-term risk, GUERF is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check ADDLF's competition here
GUERF vs CZMWF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, CZMWF has a market cap of 4.7B. Regarding current trading prices, GUERF is priced at $22.25, while CZMWF trades at $53.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CZMWF's P/E ratio is 26.36. In terms of profitability, GUERF's ROE is N/A, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, GUERF and CZMWF have similar daily volatility (0.00).Check CZMWF's competition here
GUERF vs CZMWY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, CZMWY has a market cap of 4.7B. Regarding current trading prices, GUERF is priced at $22.25, while CZMWY trades at $53.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CZMWY's P/E ratio is 26.49. In terms of profitability, GUERF's ROE is N/A, compared to CZMWY's ROE of +0.07%. Regarding short-term risk, GUERF is less volatile compared to CZMWY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check CZMWY's competition here
GUERF vs AHICF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, AHICF has a market cap of 4.4B. Regarding current trading prices, GUERF is priced at $22.25, while AHICF trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas AHICF's P/E ratio is 59.89. In terms of profitability, GUERF's ROE is N/A, compared to AHICF's ROE of +0.07%. Regarding short-term risk, GUERF and AHICF have similar daily volatility (0.00).Check AHICF's competition here
GUERF vs TEVNF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, TEVNF has a market cap of 3.2B. Regarding current trading prices, GUERF is priced at $22.25, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TEVNF's P/E ratio is -0.21. In terms of profitability, GUERF's ROE is N/A, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, GUERF and TEVNF have similar daily volatility (0.00).Check TEVNF's competition here
GUERF vs ANSLY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, ANSLY has a market cap of 3B. Regarding current trading prices, GUERF is priced at $22.25, while ANSLY trades at $83.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ANSLY's P/E ratio is 25.72. In terms of profitability, GUERF's ROE is N/A, compared to ANSLY's ROE of +0.04%. Regarding short-term risk, GUERF and ANSLY have similar daily volatility (0.00).Check ANSLY's competition here
GUERF vs SHWGF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SHWGF has a market cap of 3B. Regarding current trading prices, GUERF is priced at $22.25, while SHWGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SHWGF's P/E ratio is 11.02. In terms of profitability, GUERF's ROE is N/A, compared to SHWGF's ROE of +0.09%. Regarding short-term risk, GUERF and SHWGF have similar daily volatility (0.00).Check SHWGF's competition here
GUERF vs ANSLF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, ANSLF has a market cap of 2.6B. Regarding current trading prices, GUERF is priced at $22.25, while ANSLF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ANSLF's P/E ratio is 22.22. In terms of profitability, GUERF's ROE is N/A, compared to ANSLF's ROE of +0.06%. Regarding short-term risk, GUERF and ANSLF have similar daily volatility (0.00).Check ANSLF's competition here
GUERF vs TCGGY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, TCGGY has a market cap of 2.6B. Regarding current trading prices, GUERF is priced at $22.25, while TCGGY trades at $40.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TCGGY's P/E ratio is 30.55. In terms of profitability, GUERF's ROE is N/A, compared to TCGGY's ROE of +0.07%. Regarding short-term risk, GUERF and TCGGY have similar daily volatility (0.00).Check TCGGY's competition here
GUERF vs TCHBF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, TCHBF has a market cap of 2.5B. Regarding current trading prices, GUERF is priced at $22.25, while TCHBF trades at $200.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TCHBF's P/E ratio is 30.72. In terms of profitability, GUERF's ROE is N/A, compared to TCHBF's ROE of +0.07%. Regarding short-term risk, GUERF and TCHBF have similar daily volatility (0.00).Check TCHBF's competition here
GUERF vs BOEUF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, BOEUF has a market cap of 2.2B. Regarding current trading prices, GUERF is priced at $22.25, while BOEUF trades at $34.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas BOEUF's P/E ratio is 148.26. In terms of profitability, GUERF's ROE is N/A, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, GUERF and BOEUF have similar daily volatility (0.00).Check BOEUF's competition here
GUERF vs EKTAF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, EKTAF has a market cap of 1.8B. Regarding current trading prices, GUERF is priced at $22.25, while EKTAF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas EKTAF's P/E ratio is 83.33. In terms of profitability, GUERF's ROE is N/A, compared to EKTAF's ROE of +0.02%. Regarding short-term risk, GUERF and EKTAF have similar daily volatility (0.00).Check EKTAF's competition here
GUERF vs EKTAY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, EKTAY has a market cap of 1.8B. Regarding current trading prices, GUERF is priced at $22.25, while EKTAY trades at $4.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas EKTAY's P/E ratio is 68.21. In terms of profitability, GUERF's ROE is N/A, compared to EKTAY's ROE of +0.02%. Regarding short-term risk, GUERF is less volatile compared to EKTAY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check EKTAY's competition here
GUERF vs GRRMF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, GRRMF has a market cap of 1.8B. Regarding current trading prices, GUERF is priced at $22.25, while GRRMF trades at $51.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas GRRMF's P/E ratio is 24.71. In terms of profitability, GUERF's ROE is N/A, compared to GRRMF's ROE of +0.05%. Regarding short-term risk, GUERF is less volatile compared to GRRMF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check GRRMF's competition here
GUERF vs NPRRF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, NPRRF has a market cap of 1.5B. Regarding current trading prices, GUERF is priced at $22.25, while NPRRF trades at $8.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas NPRRF's P/E ratio is 43.32. In terms of profitability, GUERF's ROE is N/A, compared to NPRRF's ROE of N/A. Regarding short-term risk, GUERF is less volatile compared to NPRRF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check NPRRF's competition here
GUERF vs TGLVY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, TGLVY has a market cap of 1.4B. Regarding current trading prices, GUERF is priced at $22.25, while TGLVY trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TGLVY's P/E ratio is 71.53. In terms of profitability, GUERF's ROE is N/A, compared to TGLVY's ROE of +0.02%. Regarding short-term risk, GUERF and TGLVY have similar daily volatility (0.00).Check TGLVY's competition here
GUERF vs TDVXF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, TDVXF has a market cap of 1.3B. Regarding current trading prices, GUERF is priced at $22.25, while TDVXF trades at $12.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TDVXF's P/E ratio is 82.87. In terms of profitability, GUERF's ROE is N/A, compared to TDVXF's ROE of +0.39%. Regarding short-term risk, GUERF is less volatile compared to TDVXF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check TDVXF's competition here
GUERF vs BITGF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, BITGF has a market cap of 1.2B. Regarding current trading prices, GUERF is priced at $22.25, while BITGF trades at $15.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas BITGF's P/E ratio is 45.50. In terms of profitability, GUERF's ROE is N/A, compared to BITGF's ROE of +0.06%. Regarding short-term risk, GUERF is less volatile compared to BITGF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check BITGF's competition here
GUERF vs PBHDF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, PBHDF has a market cap of 1.1B. Regarding current trading prices, GUERF is priced at $22.25, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, GUERF's ROE is N/A, compared to PBHDF's ROE of +0.07%. Regarding short-term risk, GUERF and PBHDF have similar daily volatility (0.00).Check PBHDF's competition here
GUERF vs SHWGY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SHWGY has a market cap of 983.6M. Regarding current trading prices, GUERF is priced at $22.25, while SHWGY trades at $3.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SHWGY's P/E ratio is 13.92. In terms of profitability, GUERF's ROE is N/A, compared to SHWGY's ROE of +0.09%. Regarding short-term risk, GUERF is less volatile compared to SHWGY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check SHWGY's competition here
GUERF vs KSRBF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, KSRBF has a market cap of 866.4M. Regarding current trading prices, GUERF is priced at $22.25, while KSRBF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas KSRBF's P/E ratio is 4.87. In terms of profitability, GUERF's ROE is N/A, compared to KSRBF's ROE of +0.03%. Regarding short-term risk, GUERF is less volatile compared to KSRBF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check KSRBF's competition here
GUERF vs NNCSF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, NNCSF has a market cap of 743.9M. Regarding current trading prices, GUERF is priced at $22.25, while NNCSF trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas NNCSF's P/E ratio is 81.67. In terms of profitability, GUERF's ROE is N/A, compared to NNCSF's ROE of +0.07%. Regarding short-term risk, GUERF is less volatile compared to NNCSF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check NNCSF's competition here
GUERF vs SAFLY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SAFLY has a market cap of 585.4M. Regarding current trading prices, GUERF is priced at $22.25, while SAFLY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SAFLY's P/E ratio is 19.08. In terms of profitability, GUERF's ROE is N/A, compared to SAFLY's ROE of +0.05%. Regarding short-term risk, GUERF and SAFLY have similar daily volatility (0.00).Check SAFLY's competition here
GUERF vs SAFLF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SAFLF has a market cap of 544.4M. Regarding current trading prices, GUERF is priced at $22.25, while SAFLF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SAFLF's P/E ratio is 22.50. In terms of profitability, GUERF's ROE is N/A, compared to SAFLF's ROE of +0.05%. Regarding short-term risk, GUERF is less volatile compared to SAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check SAFLF's competition here
GUERF vs JNDOF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, JNDOF has a market cap of 531M. Regarding current trading prices, GUERF is priced at $22.25, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, GUERF's ROE is N/A, compared to JNDOF's ROE of +0.20%. Regarding short-term risk, GUERF is less volatile compared to JNDOF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check JNDOF's competition here
GUERF vs HGYMF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, HGYMF has a market cap of 510.1M. Regarding current trading prices, GUERF is priced at $22.25, while HGYMF trades at $23.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas HGYMF's P/E ratio is 32.86. In terms of profitability, GUERF's ROE is N/A, compared to HGYMF's ROE of +0.02%. Regarding short-term risk, GUERF is less volatile compared to HGYMF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check HGYMF's competition here
GUERF vs SPMXF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SPMXF has a market cap of 458.6M. Regarding current trading prices, GUERF is priced at $22.25, while SPMXF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SPMXF's P/E ratio is -15.00. In terms of profitability, GUERF's ROE is N/A, compared to SPMXF's ROE of -0.05%. Regarding short-term risk, GUERF is less volatile compared to SPMXF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check SPMXF's competition here
GUERF vs CLHLF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, CLHLF has a market cap of 455.6M. Regarding current trading prices, GUERF is priced at $22.25, while CLHLF trades at $76.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CLHLF's P/E ratio is 34.82. In terms of profitability, GUERF's ROE is N/A, compared to CLHLF's ROE of +0.12%. Regarding short-term risk, GUERF is less volatile compared to CLHLF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check CLHLF's competition here
GUERF vs TSNLF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, TSNLF has a market cap of 252.4M. Regarding current trading prices, GUERF is priced at $22.25, while TSNLF trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TSNLF's P/E ratio is 33.06. In terms of profitability, GUERF's ROE is N/A, compared to TSNLF's ROE of +0.21%. Regarding short-term risk, GUERF is less volatile compared to TSNLF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check TSNLF's competition here
GUERF vs OPSSF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, OPSSF has a market cap of 247.4M. Regarding current trading prices, GUERF is priced at $22.25, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, GUERF's ROE is N/A, compared to OPSSF's ROE of -0.36%. Regarding short-term risk, GUERF is less volatile compared to OPSSF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check OPSSF's competition here
GUERF vs MCDA Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, MCDA has a market cap of 212M. Regarding current trading prices, GUERF is priced at $22.25, while MCDA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas MCDA's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to MCDA's ROE of N/A. Regarding short-term risk, GUERF is less volatile compared to MCDA. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check MCDA's competition here
GUERF vs EEOIF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, GUERF is priced at $22.25, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, GUERF's ROE is N/A, compared to EEOIF's ROE of N/A. Regarding short-term risk, GUERF and EEOIF have similar daily volatility (0.00).Check EEOIF's competition here
GUERF vs UEEC Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, UEEC has a market cap of 21.2M. Regarding current trading prices, GUERF is priced at $22.25, while UEEC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas UEEC's P/E ratio is -8.25. In terms of profitability, GUERF's ROE is N/A, compared to UEEC's ROE of +1.31%. Regarding short-term risk, GUERF is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check UEEC's competition here
GUERF vs GVDI Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, GVDI has a market cap of 15.8M. Regarding current trading prices, GUERF is priced at $22.25, while GVDI trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas GVDI's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to GVDI's ROE of +0.00%. Regarding short-term risk, GUERF is less volatile compared to GVDI. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check GVDI's competition here
GUERF vs OTCFF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, OTCFF has a market cap of 13.4M. Regarding current trading prices, GUERF is priced at $22.25, while OTCFF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas OTCFF's P/E ratio is -9.64. In terms of profitability, GUERF's ROE is N/A, compared to OTCFF's ROE of -7.85%. Regarding short-term risk, GUERF and OTCFF have similar daily volatility (0.00).Check OTCFF's competition here
GUERF vs OJSY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, OJSY has a market cap of 9.1M. Regarding current trading prices, GUERF is priced at $22.25, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas OJSY's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to OJSY's ROE of N/A. Regarding short-term risk, GUERF is less volatile compared to OJSY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check OJSY's competition here
GUERF vs RSCF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, RSCF has a market cap of 6.4M. Regarding current trading prices, GUERF is priced at $22.25, while RSCF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas RSCF's P/E ratio is -7.50. In terms of profitability, GUERF's ROE is N/A, compared to RSCF's ROE of +0.08%. Regarding short-term risk, GUERF and RSCF have similar daily volatility (0.00).Check RSCF's competition here
GUERF vs IMTH Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, IMTH has a market cap of 5.8M. Regarding current trading prices, GUERF is priced at $22.25, while IMTH trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas IMTH's P/E ratio is -0.29. In terms of profitability, GUERF's ROE is N/A, compared to IMTH's ROE of +2.29%. Regarding short-term risk, GUERF is less volatile compared to IMTH. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check IMTH's competition here
GUERF vs BLMHF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, GUERF is priced at $22.25, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, GUERF's ROE is N/A, compared to BLMHF's ROE of N/A. Regarding short-term risk, GUERF and BLMHF have similar daily volatility (0.00).Check BLMHF's competition here
GUERF vs TUTH Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, TUTH has a market cap of 4.9M. Regarding current trading prices, GUERF is priced at $22.25, while TUTH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TUTH's P/E ratio is -2.05. In terms of profitability, GUERF's ROE is N/A, compared to TUTH's ROE of +0.31%. Regarding short-term risk, GUERF and TUTH have similar daily volatility (0.00).Check TUTH's competition here
GUERF vs PXMVF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, GUERF is priced at $22.25, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, GUERF's ROE is N/A, compared to PXMVF's ROE of N/A. Regarding short-term risk, GUERF is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check PXMVF's competition here
GUERF vs YBGJ Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, YBGJ has a market cap of 4.3M. Regarding current trading prices, GUERF is priced at $22.25, while YBGJ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas YBGJ's P/E ratio is -1.79. In terms of profitability, GUERF's ROE is N/A, compared to YBGJ's ROE of +3.46%. Regarding short-term risk, GUERF and YBGJ have similar daily volatility (0.00).Check YBGJ's competition here
GUERF vs CBSC Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, CBSC has a market cap of 4.3M. Regarding current trading prices, GUERF is priced at $22.25, while CBSC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CBSC's P/E ratio is -3.80. In terms of profitability, GUERF's ROE is N/A, compared to CBSC's ROE of +1.21%. Regarding short-term risk, GUERF and CBSC have similar daily volatility (0.00).Check CBSC's competition here
GUERF vs ECIA Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, ECIA has a market cap of 4.1M. Regarding current trading prices, GUERF is priced at $22.25, while ECIA trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ECIA's P/E ratio is -17.35. In terms of profitability, GUERF's ROE is N/A, compared to ECIA's ROE of -0.33%. Regarding short-term risk, GUERF is less volatile compared to ECIA. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check ECIA's competition here
GUERF vs NSTGQ Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, GUERF is priced at $22.25, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to NSTGQ's ROE of N/A. Regarding short-term risk, GUERF is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check NSTGQ's competition here
GUERF vs PDMI Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, GUERF is priced at $22.25, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas PDMI's P/E ratio is -0.01. In terms of profitability, GUERF's ROE is N/A, compared to PDMI's ROE of +0.19%. Regarding short-term risk, GUERF and PDMI have similar daily volatility (0.00).Check PDMI's competition here
GUERF vs REMI Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, REMI has a market cap of 200K. Regarding current trading prices, GUERF is priced at $22.25, while REMI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas REMI's P/E ratio is -1.00. In terms of profitability, GUERF's ROE is N/A, compared to REMI's ROE of -0.08%. Regarding short-term risk, GUERF and REMI have similar daily volatility (0.00).Check REMI's competition here
GUERF vs WHSI Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, WHSI has a market cap of 182.7K. Regarding current trading prices, GUERF is priced at $22.25, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas WHSI's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to WHSI's ROE of +0.84%. Regarding short-term risk, GUERF and WHSI have similar daily volatility (0.00).Check WHSI's competition here
GUERF vs BLFE Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, BLFE has a market cap of 156.7K. Regarding current trading prices, GUERF is priced at $22.25, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas BLFE's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to BLFE's ROE of +0.00%. Regarding short-term risk, GUERF and BLFE have similar daily volatility (0.00).Check BLFE's competition here
GUERF vs CEOS Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, CEOS has a market cap of 118.4K. Regarding current trading prices, GUERF is priced at $22.25, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CEOS's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to CEOS's ROE of +1.18%. Regarding short-term risk, GUERF is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check CEOS's competition here
GUERF vs QTXB Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, GUERF is priced at $22.25, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas QTXB's P/E ratio is -0.05. In terms of profitability, GUERF's ROE is N/A, compared to QTXB's ROE of +0.00%. Regarding short-term risk, GUERF is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check QTXB's competition here
GUERF vs SDCCQ Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SDCCQ has a market cap of 40.3K. Regarding current trading prices, GUERF is priced at $22.25, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, GUERF and SDCCQ have similar daily volatility (0.00).Check SDCCQ's competition here
GUERF vs LANZ Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, LANZ has a market cap of 27.7K. Regarding current trading prices, GUERF is priced at $22.25, while LANZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas LANZ's P/E ratio is 1.00. In terms of profitability, GUERF's ROE is N/A, compared to LANZ's ROE of +0.01%. Regarding short-term risk, GUERF and LANZ have similar daily volatility (0.00).Check LANZ's competition here
GUERF vs GMVDF Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, GMVDF has a market cap of 26K. Regarding current trading prices, GUERF is priced at $22.25, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas GMVDF's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, GUERF and GMVDF have similar daily volatility (0.00).Check GMVDF's competition here
GUERF vs VSMD Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, VSMD has a market cap of 22.4K. Regarding current trading prices, GUERF is priced at $22.25, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas VSMD's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to VSMD's ROE of +3.15%. Regarding short-term risk, GUERF is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check VSMD's competition here
GUERF vs ASFX Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, ASFX has a market cap of 17.5K. Regarding current trading prices, GUERF is priced at $22.25, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ASFX's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to ASFX's ROE of +0.00%. Regarding short-term risk, GUERF and ASFX have similar daily volatility (0.00).Check ASFX's competition here
GUERF vs MDIT Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, MDIT has a market cap of 17.2K. Regarding current trading prices, GUERF is priced at $22.25, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas MDIT's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to MDIT's ROE of -0.99%. Regarding short-term risk, GUERF is less volatile compared to MDIT. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check MDIT's competition here
GUERF vs INND Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, INND has a market cap of 12.1K. Regarding current trading prices, GUERF is priced at $22.25, while INND trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas INND's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to INND's ROE of +0.32%. Regarding short-term risk, GUERF is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check INND's competition here
GUERF vs LFPI Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, LFPI has a market cap of 10.2K. Regarding current trading prices, GUERF is priced at $22.25, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas LFPI's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to LFPI's ROE of -4.85%. Regarding short-term risk, GUERF is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check LFPI's competition here
GUERF vs SECI Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SECI has a market cap of 9.2K. Regarding current trading prices, GUERF is priced at $22.25, while SECI trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SECI's P/E ratio is -0.18. In terms of profitability, GUERF's ROE is N/A, compared to SECI's ROE of -0.00%. Regarding short-term risk, GUERF is less volatile compared to SECI. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check SECI's competition here
GUERF vs DGEN Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, GUERF is priced at $22.25, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas DGEN's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to DGEN's ROE of +0.05%. Regarding short-term risk, GUERF and DGEN have similar daily volatility (0.00).Check DGEN's competition here
GUERF vs SVSO Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SVSO has a market cap of 2.6K. Regarding current trading prices, GUERF is priced at $22.25, while SVSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SVSO's P/E ratio is -0.01. In terms of profitability, GUERF's ROE is N/A, compared to SVSO's ROE of +0.17%. Regarding short-term risk, GUERF and SVSO have similar daily volatility (0.00).Check SVSO's competition here
GUERF vs SEYE Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, SEYE has a market cap of 1.2K. Regarding current trading prices, GUERF is priced at $22.25, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SEYE's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to SEYE's ROE of N/A. Regarding short-term risk, GUERF and SEYE have similar daily volatility (0.00).Check SEYE's competition here
GUERF vs BGMD Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, BGMD has a market cap of 1.1K. Regarding current trading prices, GUERF is priced at $22.25, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas BGMD's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to BGMD's ROE of +0.00%. Regarding short-term risk, GUERF is less volatile compared to BGMD. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check BGMD's competition here
GUERF vs ADLI Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, GUERF is priced at $22.25, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ADLI's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to ADLI's ROE of +1.36%. Regarding short-term risk, GUERF is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.Check ADLI's competition here
GUERF vs HRAL Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, HRAL has a market cap of 396. Regarding current trading prices, GUERF is priced at $22.25, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas HRAL's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to HRAL's ROE of +0.13%. Regarding short-term risk, GUERF and HRAL have similar daily volatility (0.00).Check HRAL's competition here
GUERF vs MICRD Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, MICRD has a market cap of 317. Regarding current trading prices, GUERF is priced at $22.25, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas MICRD's P/E ratio is -0.00. In terms of profitability, GUERF's ROE is N/A, compared to MICRD's ROE of -0.25%. Regarding short-term risk, GUERF and MICRD have similar daily volatility (0.00).Check MICRD's competition here
GUERF vs RGBOQ Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, GUERF is priced at $22.25, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, GUERF's ROE is N/A, compared to RGBOQ's ROE of N/A. Regarding short-term risk, GUERF and RGBOQ have similar daily volatility (0.00).Check RGBOQ's competition here
GUERF vs VTEQ Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, GUERF is priced at $22.25, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, GUERF's ROE is N/A, compared to VTEQ's ROE of N/A. Regarding short-term risk, GUERF and VTEQ have similar daily volatility (0.00).Check VTEQ's competition here
GUERF vs OCPNY Comparison August 2025
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281M. In comparison, OCPNY has a market cap of 0. Regarding current trading prices, GUERF is priced at $22.25, while OCPNY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas OCPNY's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to OCPNY's ROE of +0.26%. Regarding short-term risk, GUERF and OCPNY have similar daily volatility (0.00).Check OCPNY's competition here